0001213900-21-022025.txt : 20210419 0001213900-21-022025.hdr.sgml : 20210419 20210419103224 ACCESSION NUMBER: 0001213900-21-022025 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210419 DATE AS OF CHANGE: 20210419 EFFECTIVENESS DATE: 20210419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Emerald Health Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001700800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820669961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-396260 FILM NUMBER: 21833586 BUSINESS ADDRESS: STREET 1: 5910 PACIFIC CENTER BLVD STREET 2: SUITE 320, CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 352-0622 MAIL ADDRESS: STREET 1: 5910 PACIFIC CENTER BLVD STREET 2: SUITE 320, CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001700800 Emerald Health Pharmaceuticals Inc. 5910 PACIFIC CENTER BLVD SUITE 320 SAN DIEGO CA CALIFORNIA 92121 (858)352-0622 DELAWARE None None Corporation true 2017 James DeMesa Emerald Health Pharmaceuticals Inc. 5910 Pacific Center Blvd., Suite 320 San Diego CA CALIFORNIA 92121 Executive Officer Director President, Chief Executive Officer and Director Lisa Sanford Emerald Health Pharmaceuticals Inc. 5910 Pacific Center Blvd., Suite 320 San Diego CA CALIFORNIA 92121 Executive Officer Chief Financial Officer Alain Rolland Emerald Health Pharmaceuticals Inc. 5910 Pacific Center Blvd., Suite 320 San Diego CA CALIFORNIA 92121 Executive Officer Chief Operating Officer Joachim Schupp Emerald Health Pharmaceuticals Inc. 5910 Pacific Center Blvd., Suite 320 San Diego CA CALIFORNIA 92121 Executive Officer Chief Medical Officer Eduardo S. Munoz Emerald Health Pharmaceuticals Inc. 5910 Pacific Center Blvd., Suite 320 San Diego CA CALIFORNIA 92121 Executive Officer Chief Scientific Officer Punit S. Dhillon Emerald Health Pharmaceuticals Inc. 5910 Pacific Center Blvd., Suite 320 San Diego CA CALIFORNIA 92121 Director James L. Heppell Emerald Health Pharmaceuticals Inc. 5910 Pacific Center Blvd., Suite 320 San Diego CA CALIFORNIA 92121 Director Gaetano A. Morello Emerald Health Pharmaceuticals Inc. 5910 Pacific Center Blvd., Suite 320 San Diego CA CALIFORNIA 92121 Director Pharmaceuticals Decline to Disclose 06b false 2021-04-12 false true true true true Underlying shares of common stock issued upon conversion (at $2.00 per share) of principal loan of $500,000. false 0 500000 500000 0 Total sale amount including 250,000 underlying shares of common stock upon conversion of $500,000 in unpaid principal ($2.00 per share) balance outstanding under the loan agreement of Issuer (as borrower) and Emerald health Sciences Inc. (as lender). false 1 0 0 0 false Emerald Health Pharmaceuticals Inc. /s/ James DeMesa James DeMesa President and Chief Executive Officer 2021-04-19